Making great products even greater
Canada’s leader in Graphene production and application solutions
Making great products even greater
Canada’s leader in Graphene production and application solutions
GLCM Biosensor Test & Platform
Our Response to COVID-19
GLC Medical (GLCM) Inc. has completed the validation of the SARS-CoV-2 vertical on the GLCM Biosensor Platform. Validation work was completed at the University of Alberta, Li Ka Shing Institute of Virology and University of Sherbrooke. The GLCM Biosensor Test Platform produces results in under one-minute and can be tailored to detect multiple pathogens. This diagnostic device represents a global breakthrough in medical diagnostics by providing real-time virus detection that is unmatched in terms of sensitivity, simplicity, and reproducibility by utilizing electrochemical impedance spectroscopy (EIS).
GLCM - Company Video
What We Do
We produce disruptive graphene-enhanced technology solutions for an evolving world market
Our Graphene
Our graphene materials serve as a platform technology to add value across numerous applications. GLC is specifically focused on the environment and coatings markets.
Products
GLC’s production of bulk nanomaterials include Graphene Oxide (GO), Reduced Graphene Oxide (rGO) and Pristine Graphene (pG) and serve as a platform of products available in customizable solvents and in flake form.
Solutions
GLC is focused on working with industries to develop solutions by integrating graphene to develop new innovative and first-to-market products and solutions.
In The News
Check out our latest news posting and publications.
GLC Medical (GLCM) Inc. to Present at Global Health Conference
GLC Medical (GLCM) Inc. to Present at the 15th Annual Health & Humanitarian Conference EDMONTON, AB, October 12, 2023 – GLC Medical (GLCM) Inc. a
GLC Medical (GLCM) Inc. Medical Diagnostic Breakthrough
GLC Medical (GLCM) Inc. Completes Development of Virus Detection Platform EDMONTON, AB, May 11, 2022 – GLC Medical (GLCM) Inc. is pleased to announce that
New technology developed in Edmonton to make taking a rapid test for COVID-19 easier may be used to detect other diseases
New technology developed in Edmonton to make taking a rapid test for COVID-19 easier may be used to detect other diseases. For the full article and
GLCM Creates Solution for COVID-19 Testing – Discussion with Mark Connolly and Tara McCarthy
Donna Mandau, President and CEO of Graphene Leaders Canada, speaks with Mark Connolly, and Tara McCarthy about going to clinical trials with the “world’s fastest” Covid-19 screening test with results in under 15 seconds.
GLCM Prepares for Clinical Trials with Instant Covid-19 Test
Donna Mandau, President and CEO of Graphene Leaders Canada, speaks with CTV News Edmonton about getting ready for clinical testing on instant Covid-19 Test – Offering results in under 15 seconds.